Under the guise of freeing trade, bilateral trade agreements (BTAs) are being used as a tool to further an absolute top-down Northern agenda, at the victimization of the poor and marginalized groups and communities of the South.
Ecuador’s opposition to US demands on access to test data for clinical drug trials has emerged as a primary obstacle in the ongoing free trade agreement (FTA) talks between the US and a group of three Andean countries.
An Economist Intelligence Unit briefing paper
US congressmen have pledged to accommodate Thailand’s concerns about drug prices and freer mobility for Thais into the United States once the two countries conclude their free trade area (FTA) agreement.
The United States began a new round of negotiations Monday with Peru, Ecuador and Colombia for a proposed free-trade agreement aimed at giving the three South American nations tariff-free access to US markets.
The Thai government should seek a consensus from the public before signing a free trade area (FTA) agreement with the United States, according to a leading academic.
This booklet by FTA Watch is aimed at disseminating information to international
civil society for the purpose of sharing the analyses and experience of the
FTA struggle in Thailand.
Pharmaceutical companies are using free-trade deals like CAFTA to eliminate
global competition — and deny poor patients access to cheaper generic
With many Peruvians already dying from treatable illness due to difficulties in accessing drugs, a UN human rights expert has expressed "deep concern" that an eventual US-Peru Free Trade Agreement (FTA) could deprive millions more of essential drugs made unaffordable by stronger protection of patents.
With many Peruvians already dying from treatable illness due to difficulties in accessing drugs, a United Nations human rights expert today voiced deep concern that an eventual United States-Peru Free Trade Agreement (FTA) could deprive millions more of essential drugs made unaffordable by stronger protection of patents.
The Pharmaceutical Research and Manufacturers of America, which represents 67 parent companies and subsidiaries that develop and make prescription and over-the-counter drugs, listed contacts with the government’s top officials overseeing international trade agreements on more lobbying reports than it did for contacts with the Food and Drug Administration, which directly oversees the industry’s products.
After tiptoeing around the issue for months, Thailand’s trade negotiators will have to finally reveal where they stand on the life-or-death question of producing cheap, generic anti-AIDS drugs.
Looking at the experience of Jordan’s pharmaceutical sector, this paper shows that the expected benefits from bilateral agreements between developed and developing countries have been largely overestimated while the costs underestimated.
As Thailand prepares for new rounds of free trade
talks with Japan and the United States, AIDS activists are voicing
increasing concern that patients here could lose access to cheap,
When George W. Bush and the U.S. pharmaceutical industry team up in Washington, you know it’s bad news for U.S. consumers. Now they are taking their show on the road — to Central America.
India and the Bay of Bengal Initiative for Multisectoral Technical and Economic Cooperation (Bimstec) member countries plan to sign a deal to provide access to each others’ markets for the pharmaceuticals and services sectors.
After letting health advocates air their opposition to the Thai-US free trade agreement (FTA) for more than a year, the Public Health Ministry yesterday unveiled its position on how Thailand should deal with drug patents.
17 NGOs from Switzerland, Norway and Liechtenstein submitted today a request to the UN Special Rapporteur on the right to health. They urge him to warn the four member states of the European Free Trade Association (EFTA: Switzerland, Norway, Iceland and Liechtenstein) not to restrict access to affordable generic medicines in Thailand.
Doctors have been warned not to fall into the fierce marketing trap of multinational drug companies which have a ’’hidden agenda’’ to sell expensive products.
The UN Committee on the Rights of the Child in recommendations made public this week warned that Free Trade Agreements (FTAs) may negatively affect
access to affordable medicines and social services for the poor.